Clinical Trial Update: A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update indicates that ELI-002 7P is being studied in KRAS/NRAS-mutated solid tumors in Phase 1/Phase 2, with the study currently Active Not Rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• ELI-002 7P

Snippet

Sponsor: Elicio Therapeutics | Conditions: Pancreatic Ductal Adenocarcinoma, Colorectal Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING